The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...

The market has misjudged the potential impact of DeepSeek's AI progress, interpreting it as a headwind for tech companies.

D Cloud, the leader in 3D digital asset management and 3D product visualization for furniture and home improvement, and ...